Intermittent lipid nanoparticle mRNA administration prevents cortical dysmyelination associated with arginase deficiency is a research paper published in Molecular Therapy — Nucleic Acids (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1S10RR23057
National Institutes of Health
Grant: R01NS100979
National Institutes of Health
Grant: R01NS110596
National Institutes of Health
Grant: R03NS114623
NCRR NIH HHS
Grant: S10 RR023057
NINDS NIH HHS
Grant: R03 NS101682
National Institutes of Health
Grant: 5R01NS100979-04
Cell and Gene Replacement Strategies for Arginase Deficiency
National Institutes of Health
Grant: 1S10RR023057-01
High-End CryoEM Instrument for the UCLA Electron Imaging Center for Nanomachines
National Institutes of Health
Grant: 1R03NS114623-01
Elucidation of the Role of the Arginase Isoforms in Normal Neuronal Development and Function
National Institutes of Health
Grant: 5R01NS110596-02
Understanding the Mechanism and Preventing the Unique Neuropathology of Arginase Deficiency
Intellectual and Developmental Disabilities Research Center
California NanoSystems Institute
FWCI
2.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals